SMAD3 and type 2 diabetes mellitus: In control subjects, HSPB1, SMAD3 and HSPA1A decreased significantly, whilst MAPKAPK5 increased significantly in controls from baseline to hypoglycemia whilst, in T2D, PPP3CA increased and EPHA2 decreased.